|
CNN3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.43259999999079E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.450500E-02 |
| Normal-vs-Stage2 |
1.776310E-02 |
| Normal-vs-Stage3 |
3.69510000042261E-07 |
| Normal-vs-Stage4 |
9.35220000330972E-08 |
| Stage1-vs-Stage2 |
2.577600E-01 |
| Stage1-vs-Stage3 |
1.434970E-04 |
| Stage1-vs-Stage4 |
4.40090000000115E-05 |
| Stage2-vs-Stage3 |
1.243830E-01 |
| Stage2-vs-Stage4 |
4.307700E-02 |
| Stage3-vs-Stage4 |
5.420400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.73510000000188E-05 |
| Normal-vs-AfricanAmerican |
5.682200E-03 |
| Normal-vs-Asian |
5.297000E-01 |
| Caucasian-vs-AfricanAmerican |
7.518000E-01 |
| Caucasian-vs-Asian |
8.311600E-01 |
| AfricanAmerican-vs-Asian |
7.719000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.88759999997234E-06 |
| Normal-vs-Female |
9.924200E-03 |
| Male-vs-Female |
3.646400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.365000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.343110E-03 |
| Normal-vs-Age(61-80Yrs) |
1.50217999999036E-05 |
| Normal-vs-Age(81-100Yrs) |
2.378300E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.072800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.075800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.253240E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.786410E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.476610E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.116400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.851200E-01 |
| Normal-vs-Grade 2 |
2.254600E-01 |
| Normal-vs-Grade 3 |
8.52070003443117E-09 |
| Normal-vs-Grade 4 |
1.17250000042368E-07 |
| Grade 1-vs-Grade 2 |
3.123200E-01 |
| Grade 1-vs-Grade 3 |
6.362200E-04 |
| Grade 1-vs-Grade 4 |
1.983950E-03 |
| Grade 2-vs-Grade 3 |
1.72640000073443E-08 |
| Grade 2-vs-Grade 4 |
8.16230000033613E-07 |
| Grade 3-vs-Grade 4 |
1.959150E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.547200E-01 |
| Normal-vs-ccB subtype |
2.14199999999387E-05 |
| ccA subtype-vs-ccB subtype |
1.991210E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.019400E-04 |
| Normal-vs-N1 |
1.70190000003956E-06 |
| N0-vs-N1 |
1.184180E-02 |
|
|
